MarketPeel
Insider Trading Intelligence
Pricing
…
AO

Alicia C. Olivo

NEO
EVP, GC & BUSINESS DEVELOPMENT · NEOGENOMICS INC · CIK 0001951869
FILING MIX · LIFETIME38%/62%
BUYS
21
SELLS
34
TOTAL VALUE
$637.9K
COMPANIES
1
ACTIVE SINCE
May 2023
HOLDINGS NOW
2,559
AVG SELL PX
$13.19
TRADE KIND
SHOWING 55 / 55
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Alicia C. Olivo, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+42.86%+2.02%+1.00%+1.02%-0.07%—
14d7+57.14%+0.52%+1.47%-0.95%-3.96%—
30d7+57.14%+0.44%+2.66%-2.22%-2.60%—
60d7+71.43%-4.69%+3.40%-8.09%-8.32%—
90d7+42.86%-1.28%+5.52%-6.80%-6.38%—
180d7+71.43%-15.97%+9.50%-23.77%-25.21%—
1y7(2 pending)+100.00%-33.33%+20.09%-53.42%-54.21%—
2y7(4 pending)+100.00%-38.53%+43.49%-82.02%-86.51%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NEO · 2,559 shares · as of May 11, 2026
036,95173,902110,853147,804202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 21 buys / 34 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
2,559——93,567May 11, 2026May 13, 2026 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
EVP, GC & Business Development
3,944——96,126May 11, 2026May 13, 2026 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
3,944——2,559May 11, 2026May 13, 2026 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
1,042——92,182May 1, 2026May 5, 2026 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
147,804——147,804Mar 1, 2026Mar 3, 2026 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
89,013——89,013Mar 1, 2026Mar 3, 2026 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
8,443——8,443Feb 23, 2026Feb 24, 2026 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
EVP, GC & Business Development
8,443——96,547Feb 23, 2026Feb 24, 2026 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
3,323——93,224Feb 23, 2026Feb 24, 2026 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
21,079——42,159Feb 21, 2026Feb 24, 2026 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
8,295——88,104Feb 21, 2026Feb 24, 2026 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
EVP, GC & Business Development
21,079——96,399Feb 21, 2026Feb 24, 2026 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
EVP, GC & Business Development
59,382——90,465Jan 13, 2026Jan 15, 2026 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
15,145——75,320Jan 13, 2026Jan 15, 2026 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
8,977——46,355Nov 25, 2025Nov 28, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE10b5-1
10b5-1 plan
20,916$12.00$251.0K31,083Nov 25, 2025Nov 28, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
EVP, GC & Business Development
8,977$10.05$90.2K51,999Nov 25, 2025Nov 28, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE10b5-1
10b5-1 plan
4,918$10.00$49.2K43,022Oct 16, 2025Oct 20, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
1,666——47,940Sep 1, 2025Sep 3, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
14——49,606Aug 1, 2025Aug 5, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
EVP, GC & Business Development
6,503——51,204May 11, 2025May 13, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
1,584——49,620May 11, 2025May 13, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
6,503——6,503May 11, 2025May 13, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
652——44,701May 1, 2025May 5, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
8,443——16,886Feb 23, 2025Feb 25, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
EVP, GC & Business Development
8,443——47,857Feb 23, 2025Feb 25, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE
EVP, GC & Business Development
2,504——45,353Feb 23, 2025Feb 25, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
107,450——107,450Feb 21, 2025Feb 25, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
63,238——63,238Feb 21, 2025Feb 25, 2025 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
59,382——59,382Jan 14, 2025Jan 16, 2025 ↗View →
NEO
NEOGENOMICS INC
SALE10b5-1
10b5-1 plan
5,175$15.36$79.5K37,129Nov 15, 2024Nov 20, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
1,666——42,147Sep 1, 2024Sep 4, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE10b5-1
10b5-1 plan
1,040$16.05$16.7K43,813Aug 15, 2024Aug 19, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
14——44,853Aug 1, 2024Aug 5, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE10b5-1
10b5-1 plan
1,049$15.74$16.5K44,867May 15, 2024May 16, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
6,502——13,006May 11, 2024Dec 3, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
General Counsel
6,502——40,998May 11, 2024Dec 3, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
1,584$14.86$23.5K39,414May 11, 2024Dec 3, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
6,502——13,006May 11, 2024May 14, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
General Counsel
6,502——45,916May 11, 2024May 14, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
1,584$14.86$23.5K39,414May 11, 2024May 14, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASE
General Counsel
6,502——40,998May 11, 2024May 14, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
652——34,496May 1, 2024May 3, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
25,329——25,329Feb 23, 2024Feb 27, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
25,330——25,330Feb 23, 2024Feb 27, 2024 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
42,344——42,344Feb 23, 2024Feb 27, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE10b5-1
10b5-1 plan
2,587$14.96$38.7K34,866Feb 15, 2024Feb 16, 2024 ↗View →
NEO
NEOGENOMICS INC
SALE10b5-1
10b5-1 plan
2,669$18.39$49.1K37,140Nov 17, 2023Nov 20, 2023 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
14——39,498Sep 30, 2023Oct 3, 2023 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
1,666——39,411Sep 1, 2023Sep 5, 2023 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
14——40,981Aug 1, 2023Aug 1, 2023 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
19,508——19,508May 11, 2023May 15, 2023 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
36,508——36,508May 11, 2023May 15, 2023 ↗View →
NEO
NEOGENOMICS INC
PURCHASEGRANT
Stock grant
19,508——19,508May 11, 2023May 15, 2023 ↗View →
NEO
NEOGENOMICS INC
SALE
General Counsel
662——40,694May 1, 2023May 3, 2023 ↗View →
Other insiders · NEO
Loading peer insiders…
About this filer
CIK 0001951869
ROLE
EVP, GC & Business Development
PRIMARY
NEO
COMPANIES
1
ACTIVE SINCE
May 2023
MARKETPEEL · /INSIDER/0001951869DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback